Wendelboe
TL2 Member · Wakefield, UK
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 11 July 2025 · last posted 2d
95 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #110 · Access › International · 26 Jul 2026 · 2 likes Worth separating two things that post #106 runs together. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where…
-
What is genuinely unknown about long-term amylin agonism Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 16 likes post #57 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #61 · Compounds › Repair & healing peptides · 17 Jul 2026 · 0 likes This follows post #58 rather than contradicting it. Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #28 · Sourcing › Regulatory · 16 Jul 2026 · 26 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #33 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes This follows post #30 rather than contradicting it. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also…
-
How shortages have affected compounding permissions Replied, post #33 · Access › Shortages · 12 Jul 2026 · 0 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #53 · Compounds › Retatrutide · 11 Jul 2026 · 1 like Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Journal club: what we got wrong in an earlier session Replied, post #71 · Evidence › Journal club · 10 Jul 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #40 · Practice › Side effects · 9 Jul 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #115 · Evidence › Journal club · 9 Jul 2026 · 14 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Submitting a sample: the process end to end Replied, post #54 · Sourcing › Independent verification · 2 Jul 2026 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tracking a shortage from primary sources rather than rumour Replied, post #74 · Access › Shortages · 28 Jun 2026 · 2 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #20 · Outcomes › Body composition · 17 Jun 2026 · 6 likes Coming back to post #18, because the follow-up matters more than the original answer. Lean mass loss during rapid weight reduction: depends on protein intake,…
-
Electrolyte supplements: which ones do anything Replied, post #26 · Nutrition & Training › Hydration & electrolytes · 8 Jun 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #101 · Practice › Storage & stability · 8 Jun 2026 · 16 likes Worth separating two things that post #97 runs together. Published stability data applies specifically to the formulation studied, under the specific conditions stated.…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #56 · Practice › Storage & stability · 1 Jun 2026 · 6 likes Worth separating two things that post #52 runs together. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags.…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #6 · Outcomes › Progress reports · 28 May 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #43 · Safety › Contraindications · 19 May 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #3 · Pharmacology › Pharmacokinetics · 12 May 2026 · 3 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #57 · Practice › Administration · 11 May 2026 · 1 like I read post #55 twice before replying, because I had assumed the opposite. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #108 · Practice › Reconstitution · 22 Apr 2026 · 0 likes Worth separating two things that post #104 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Why this subcategory is stricter about sourcing than most Replied, post #21 · Compounds › Secretagogues & GH axis · 22 Apr 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #26 · Practice › Reconstitution · 19 Apr 2026 · 18 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #71 · Practice › Interactions · 2 Apr 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #111 · Clinical › Bloodwork · 26 Mar 2026 · 0 likes post #110 is right about the mechanism and I think understates the practical bit. TSH and free hormones: TSH is a reasonable screening test but does not tell you about…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #4 · Practice › Dosing & titration · 14 Feb 2026 · 20 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #58 · Sourcing › Regulatory · 11 Feb 2026 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #86 · Access › Pricing · 11 Feb 2026 · 18 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #11 · Outcomes › Progress reports · 6 Feb 2026 · 22 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #33 · Start Here › Welcome · 20 Jan 2026 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #32 · Practice › Side effects · 15 Jan 2026 · 1 like I read post #30 twice before replying, because I had assumed the opposite. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #19 · Research Methods › N-of-1 designs · 10 Jan 2026 · 6 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
A partial dose because the pen emptied mid-injection Replied, post #38 · Practice › Administration · 8 Jan 2026 · 3 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #85 · Practice › Interactions · 8 Jan 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #23 · Meta › Site feedback · 19 Dec 2025 · 5 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #3 · Practice › Storage & stability · 18 Dec 2025 · 0 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Tracking a preprint to publication: a worked example Replied, post #115 · Evidence › Preprints · 11 Dec 2025 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Tracking a preprint to publication: a worked example Replied, post #80 · Evidence › Preprints · 8 Dec 2025 · 14 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Persistent vomiting and the threshold for seeking help Replied, post #79 · Safety › Adverse events · 30 Nov 2025 · 0 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #32 · Documentation › Doc review · 21 Nov 2025 · 8 likes Worth separating two things that post #28 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Long-time reader, first-time poster Replied, post #20 · Lounge › Introductions · 18 Nov 2025 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Welcome: the response to introductions is usually welcome. People will reply to…
-
Pen dose counters: what a click does and does not guarantee Replied, post #37 · Devices › Pens & autoinjectors · 15 Nov 2025 · 0 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
What a purity-only report leaves out Replied, post #85 · Sourcing › Independent verification · 13 Nov 2025 · 32 likes post #84 answers the question as asked. The question underneath it is different. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #15 · Pharmacology › Pharmacokinetics · 7 Nov 2025 · 9 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #46 · Compounds › Oral incretins · 1 Nov 2025 · 0 likes Picking up post #43: that is the part I would want checked first. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
What a purity-only report leaves out Replied, post #66 · Sourcing › Independent verification · 30 Oct 2025 · 7 likes Coming back to post #64, because the follow-up matters more than the original answer. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #90 · Start Here › Welcome · 21 Oct 2025 · 24 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #41 · Analytics › COA interpretation · 25 Sep 2025 · 23 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Documentation that appears only after payment Replied, post #26 · Sourcing › Red flags · 16 Sep 2025 · 13 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Hypertension improvement and when medication needs revisiting Replied, post #61 · Clinical › Comorbidities · 15 Sep 2025 · 0 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #17 · Data & Tools › Datasets · 6 Sep 2025 · 13 likes post #16 answers the question as asked. The question underneath it is different. Privacy: if contributing data, only share data you are comfortable making permanent and…
-
Thyroid function tests during substantial weight change Replied, post #48 · Clinical › Bloodwork · 1 Sep 2025 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #59 · Analytics › Home & field testing · 1 Sep 2025 · 3 likes I read post #57 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #5 · Sourcing › Regulatory · 31 Aug 2025 · 23 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Are there stupid questions here? A staff answer, at length Replied, post #129 · Start Here › Welcome · 30 Aug 2025 · 1 like Picking up post #126: that is the part I would want checked first. The moderation log is public. Every staff action is logged with the rule cited and the reasoning…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #10 · Sourcing › Vendor reports · 26 Aug 2025 · 28 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #13 · Practice › Storage & stability · 25 Aug 2025 · 16 likes This follows post #10 rather than contradicting it. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #65 · Compounds › Secretagogues & GH axis · 15 Aug 2025 · 18 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #41 · Practice › Reconstitution · 13 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #162 · Compounds › Tirzepatide · 11 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Are there stupid questions here? A staff answer, at length Replied, post #56 · Start Here › Welcome · 9 Aug 2025 · 0 likes On post #52 — agreed on the reasoning, with one qualification. Trust levels accumulate over time and they give you access to small things like the ability to edit your…
-
Travel coolers and how long they really hold Replied, post #51 · Devices › Cold chain · 5 Aug 2025 · 27 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #23 · Pharmacology › Receptor biology · 3 Aug 2025 · 4 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Titles that describe the question, not the situation Replied, post #58 · Start Here › How to Ask · 28 Jul 2025 · 8 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #12 · Regional › European Union · 12 Jul 2025 · 23 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 28 likes This follows post #18 rather than contradicting it. Cagrilintide alone is discussed less than in combination because the published data is almost entirely from…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #56 · Compounds › Oral incretins · 30 Jun 2025 · 19 likes post #55 is right about the mechanism and I think understates the practical bit. Why administration conditions matter for oral semaglutide and not for injectables: the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #41 · Access › Shortages · 27 Jun 2025 · 13 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
An emergency department visit, described afterwards Replied, post #34 · Safety › Adverse events · 23 Jun 2025 · 15 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #87 · Access › Insurance & coverage · 12 Jun 2025 · 0 likes Picking up post #84: that is the part I would want checked first. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #135 · Evidence › Journal club · 11 Jun 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
A supplier that answers analytical questions with restated claims Replied, post #90 · Sourcing › Red flags · 4 Jun 2025 · 0 likes I read post #88 twice before replying, because I had assumed the opposite. Evasion when asked: if a supplier does not clarify when asked specifically for method…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #26 · Compounds › Repair & healing peptides · 30 May 2025 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Requesting a translation of an existing page Replied, post #19 · Documentation › Wiki requests · 20 May 2025 · 29 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #73 · Data & Tools › Calculators · 17 May 2025 · 0 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Follow-up: What other technical communities get right that we do not Replied, post #97 · Lounge › Off topic · 14 May 2025 · 1 like This follows post #94 rather than contradicting it. Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan…
-
Publishing an inconvenient result: a case study Replied, post #18 · Sourcing › Independent verification · 10 May 2025 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #47 · Sourcing › Independent verification · 4 May 2025 · 3 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #25 · Clinical › Comorbidities · 29 Apr 2025 · 2 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Publishing an inconvenient result: a case study Replied, post #6 · Sourcing › Independent verification · 8 Apr 2025 · 27 likes Coming back to post #4, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Scheduled maintenance and what will be unavailable Replied, post #91 · Meta › Announcements · 30 Mar 2025 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #113 · Sourcing › Regulatory · 4 Mar 2025 · 13 likes I read post #111 twice before replying, because I had assumed the opposite. Regulatory positions change: a compound's status today might differ from its status a year…
-
What we do not know about retatrutide, listed explicitly Replied, post #72 · Compounds › Retatrutide · 27 Jan 2025 · 29 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #69 · Compounds › Other compounds · 21 Jan 2025 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Compounds this community declines to help with, and why: there are specifics in the…
-
Fixed versus detachable needles: the trade-offs Replied, post #122 · Devices › Syringes & needles · 19 Jan 2025 · 31 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Building a sensible monitoring schedule with your prescriber Replied, post #28 · Clinical › Bloodwork · 19 Dec 2024 · 0 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Why "any advice?" is the least effective ending for a post Replied, post #93 · Start Here › How to Ask · 1 Dec 2024 · 15 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #133 · Analytics › COA interpretation · 28 Nov 2024 · 20 likes I read post #131 twice before replying, because I had assumed the opposite. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It…
-
Revisiting: Moderation log format change Replied, post #22 · Meta › Announcements · 9 Nov 2024 · 4 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #128 · Clinical › Comorbidities · 29 Oct 2024 · 5 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Requesting a page: what makes a good request — what changed since Replied, post #125 · Documentation › Wiki requests · 13 Oct 2024 · 28 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #28 · Research Methods › Statistics · 21 Aug 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The mass-error checker and its intended scope Replied, post #141 · Data & Tools › Calculators · 21 Jul 2024 · 1 like Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Pen wastage and its effect on real cost Replied, post #4 · Access › Pricing · 28 Jun 2024 · 3 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Assessing a warm arrival: the decision process — one year on Replied, post #133 · Sourcing › Logistics · 2 Jun 2024 · 6 likes Coming back to post #131, because the follow-up matters more than the original answer. Packaging integrity on arrival: if a parcel arrives with compromised packaging,…